These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34403937)

  • 1. Identification of phenylcarbamoylazinane-1,3,4-oxadiazole amides as lipoxygenase inhibitors with expression analysis and in silico studies.
    Bashir B; Shahid W; Ashraf M; Saleem M; Aziz-Ur-Rehman ; Muzaffar S; Imran M; Amjad H; Bhattarai K; Riaz N
    Bioorg Chem; 2021 Oct; 115():105243. PubMed ID: 34403937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing p-tolyloxy-1,3,4-oxadiazole acetamides as lipoxygenase inhibitors assisted by in vitro and in silico studies.
    Bashir B; Riaz N; Abida Ejaz S; Saleem M; Ashraf M; Iqbal A; Muzaffar S; Ejaz S; Aziz-Ur-Rehman ; Mohammad Kashif Mahmood H; Bhattarai K
    Bioorg Chem; 2022 Dec; 129():106144. PubMed ID: 36116325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring phenylcarbamoylazinane-1,2,4-triazole thioethers as lipoxygenase inhibitors supported with in vitro, in silico and cytotoxic studies.
    Shahid W; Ashraf M; Saleem M; Bashir B; Muzaffar S; Ali M; Kaleem A; Aziz-Ur-Rehman ; Amjad H; Bhattarai K; Riaz N
    Bioorg Chem; 2021 Oct; 115():105261. PubMed ID: 34416506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing phenylcarbamoylazinane-1,2,4-triazole amides derivatives as lipoxygenase inhibitors along with cytotoxic, ADME and molecular docking studies.
    Muzaffar S; Shahid W; Riaz N; Saleem M; Ashraf M; Aziz-Ur-Rehman ; Bashir B; Kaleem A; Al-Rashida M; Baral B; Bhattarai K; Gross H
    Bioorg Chem; 2021 Feb; 107():104525. PubMed ID: 33317840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular hybrids of substituted phenylcarbamoylpiperidine and 1,2,4-triazole methylacetamide as potent 15-LOX inhibitors: Design, synthesis, DFT calculations and molecular docking studies.
    Nawaz Z; Riaz N; Saleem M; Iqbal A; Abida Ejaz S; Bashir B; Muzaffar S; Ashraf M; Aziz-Ur-Rehman ; Sajjad Bilal M; Krishna Prabhala B; Sajid S
    Bioorg Chem; 2024 Feb; 143():106984. PubMed ID: 38056389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigations of
    Bashir B; Riaz N; Ejaz SA; Saleem M; Iqbal A; Ashraf M; Ejaz S; -Rehman AU; Aziz M; Bhattarai K
    J Biomol Struct Dyn; 2023; 41(24):15549-15568. PubMed ID: 36946200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of NSAIDs as lipoxygenase inhibitors through highly sensitive chemiluminescence method, expression analysis in mononuclear cells and computational studies.
    Shahid W; Ejaz SA; Al-Rashida M; Saleem M; Ahmed M; Rahman J; Riaz N; Ashraf M
    Bioorg Chem; 2021 May; 110():104818. PubMed ID: 33784531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and SAR studies of 3-allyl-4-prenyloxyaniline amides as potent 15-lipoxygenase inhibitors.
    Jabbari A; Davoodnejad M; Alimardani M; Assadieskandar A; Sadeghian A; Safdari H; Movaffagh J; Sadeghian H
    Bioorg Med Chem; 2012 Sep; 20(18):5518-26. PubMed ID: 22917856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinoline-based imidazole-fused heterocycles as new inhibitors of 15-lipoxygenase.
    Dianat S; Moghimi S; Mahdavi M; Nadri H; Moradi A; Firoozpour L; Emami S; Mouradzadegun A; Shafiee A; Foroumadi A
    J Enzyme Inhib Med Chem; 2016; 31(sup3):205-209. PubMed ID: 27424740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterization and biological screening of N-substituted derivatives of 5-benzyl-1,3,4-oxadiazole-2yl-2"-sulfanyl acetamide.
    Siddiqui SZ; Rehman A; Abbasi MA; Abbas N; Khan KM; Ashraf M; Ejaz SA
    Pak J Pharm Sci; 2013 May; 26(3):455-63. PubMed ID: 23625417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, SAR, and series evolution of novel oxadiazole-containing 5-lipoxygenase activating protein inhibitors: discovery of 2-[4-(3-{(r)-1-[4-(2-amino-pyrimidin-5-yl)-phenyl]-1-cyclopropyl-ethyl}-[1,2,4]oxadiazol-5-yl)-pyrazol-1-yl]-N,N-dimethyl-acetamide (BI 665915).
    Takahashi H; Riether D; Bartolozzi A; Bosanac T; Berger V; Binetti R; Broadwater J; Chen Z; Crux R; De Lombaert S; Dave R; Dines JA; Fadra-Khan T; Flegg A; Garrigou M; Hao MH; Huber J; Hutzler JM; Kerr S; Kotey A; Liu W; Lo HY; Loke PL; Mahaney PE; Morwick TM; Napier S; Olague A; Pack E; Padyana AK; Thomson DS; Tye H; Wu L; Zindell RM; Abeywardane A; Simpson T
    J Med Chem; 2015 Feb; 58(4):1669-90. PubMed ID: 25671290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis, molecular modelling and biological evaluation of novel 3-(2-naphthyl)-1-phenyl-1H-pyrazole derivatives as potent antioxidants and 15-Lipoxygenase inhibitors.
    Ali SA; Awad SM; Said AM; Mahgoub S; Taha H; Ahmed NM
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):847-863. PubMed ID: 32216479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, biological evaluation and docking study of 3-aroyl-1-(4-sulfamoylphenyl)thiourea derivatives as 15-lipoxygenase inhibitors.
    Mahdavi M; Shirazi MS; Taherkhani R; Saeedi M; Alipour E; Moghadam FH; Moradi A; Nadri H; Emami S; Firoozpour L; Shafiee A; Foroumadi A
    Eur J Med Chem; 2014 Jul; 82():308-13. PubMed ID: 24927051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis, biological evaluation and docking studies of new 3-(4,5-dihydro-1H-pyrazol/isoxazol-5-yl)-2-phenyl-1H-indole derivatives as potent antioxidants and 15-lipoxygenase inhibitors.
    ElBordiny HS; El-Miligy MM; Kassab SE; Daabees H; Mohamed Ali WA; Abdelhamid Mohamed El-Hawash S
    Eur J Med Chem; 2018 Feb; 145():594-605. PubMed ID: 29339254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of pyrazole acrylic acid based oxadiazole and amide derivatives as antimalarial and anticancer agents.
    Verma G; Chashoo G; Ali A; Khan MF; Akhtar W; Ali I; Akhtar M; Alam MM; Shaquiquzzaman M
    Bioorg Chem; 2018 Apr; 77():106-124. PubMed ID: 29353728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Probing
    Nawaz Z; Riaz N; Saleem M; Iqbal A; Ejaz SA; Muzaffar S; Bashir B; Ashraf M; Rehman AU; Bilal MS; Prabhala BK; Sajid S
    Heliyon; 2024 Sep; 10(17):e35278. PubMed ID: 39281606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, biological evaluation and docking study of 1,3,4-thiadiazole-thiazolidinone hybrids as anti-inflammatory agents with dual inhibition of COX-2 and 15-LOX.
    Omar YM; Abdu-Allah HHM; Abdel-Moty SG
    Bioorg Chem; 2018 Oct; 80():461-471. PubMed ID: 29986191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of natural 15-LOX small molecule inhibitors from Chinese herbal medicine using virtual Screening, biological evaluation and molecular dynamics studies.
    Li Y; Zhang Y; Wu X; Gao Y; Guo J; Tian Y; Lin Z; Wang X
    Bioorg Chem; 2021 Oct; 115():105197. PubMed ID: 34426159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel aryl carboximidamide and 3-aryl-1,2,4-oxadiazole analogues of naproxen as dual selective COX-2/15-LOX inhibitors: Design, synthesis and docking studies.
    Youssif BGM; Mohamed MFA; Al-Sanea MM; Moustafa AH; Abdelhamid AA; Gomaa HAM
    Bioorg Chem; 2019 Apr; 85():577-584. PubMed ID: 30878890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, biological evaluation and docking study of novel indole-2-amide as anti-inflammatory agents with dual inhibition of COX and 5-LOX.
    Huang Y; Zhang B; Li J; Liu H; Zhang Y; Yang Z; Liu W
    Eur J Med Chem; 2019 Oct; 180():41-50. PubMed ID: 31299586
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.